chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue, malaise for 3 weeks post vax #5. Right elbow -  joint pain, finger joint pain bilateral. Chronic fatigue, same day onset.
I had shortness of breath, low grade fever and a cough. I also had vertigo, but I think unrelated to the COVID-19.
muscle pain; cold; chills; achy all over; sweating at night; joint pain; left arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain), NASOPHARYNGITIS (cold), CHILLS (chills), PAIN IN EXTREMITY (achy all over) and HYPERHIDROSIS (sweating at night) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN (left arm was a little sore). On 05-Feb-2021, the patient experienced MYALGIA (muscle pain), NASOPHARYNGITIS (cold), CHILLS (chills), PAIN IN EXTREMITY (achy all over), HYPERHIDROSIS (sweating at night) and ARTHRALGIA (joint pain). On 06-Feb-2021, MYALGIA (muscle pain), NASOPHARYNGITIS (cold), CHILLS (chills), PAIN IN EXTREMITY (achy all over), HYPERHIDROSIS (sweating at night) and ARTHRALGIA (joint pain) had resolved. At the time of the report, PAIN (left arm was a little sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Information has been received from a nurse concerning an 82 year old female who on 08-NOV-2006 was vaccinated in the right arm with Zostavax (Oka/Merck) (625925/0621F).  On 15-JUN-2007 the patient experienced shingles.  The patient recovered on 29-JUN-2007.  Additional information has been requested.
This case was reported by a healthcare professional and described the occurrence of anuria in a 4-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 20 August 2014, the subject received 2nd dose of ROTARIX. The dose was inadvertently administered intramuscularly, in the right thigh. On 21 August 2014, 1 day after vaccination with ROTARIX, the subject experienced anuria for 5 hours, fever at 102 Deg. F, rash on cheek of face, lethargy, diarrhea (1 episode), runny nose, cough, throat erythema and erythema of ear. The subject was also not eating well. The healthcare professional considered the events were clinically significant (or requiring intervention). On 22 August 2014, the events were resolved.
Client received Moderna, 1st dose vaccine. During the 15 minute observation, she told me she was having an anxiety attack. A nurse attended her and she began to faint. 911 was called. Once EMT arrived, she was moved to the ambulance. Her vitals taken by EMT: Sugar level 131, BP 11/80, Pulse 90 at 1712, Client requested to be taken to the hospital.
19MAR91 pt vax; exp itching, maculopapaular rash, dyspnea, facial swelling, & shortness of breath.  Tx w/ Benadryl, Ativan, & Prednisone.  Psoriasis flared.
Severe head pain, not a headache, severe throbbing searing pain in the head, causing nausea still present 14 hours after the head pain started
sore arm, like someone punched hard; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2022, the patient received the 1st dose of Shingrix. On 24th December 2022, less than 2 months after receiving Shingrix, the patient experienced pain in arm. On 24th December 2022, the outcome of the pain in arm was recovered/resolved.   The reporter considered the pain in arm to be possibly related to Shingrix.     Additional Information: GSK Receipt Date: 24-DEC-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient got 1st dose last month and would get 2nd dose in January 2023. The patients arm was sore like someone punched hard for about half a day. The patient was ok after that. The follow-up could not be possible as no contact details were available.
No adverse events 15 yr old given pediatric dose Dtap, state health informed, no further update necessary. Pt asymptomatic, was ordered Td 0.5ml.
I have swelling and pain in my right leg. I went to the doctor about this.  He did an ultra sound and found a blood clot.  They gave me blood thinners to help with blood clotting. It has not gotten any better, I believe that the blood clot gotten bigger.
Received 1st dose in May2019, 2nd dose not taken yet; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in May 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not applicable for this report. The patient did not receive 2nd dose of Shingrix till the time of reporting, which led to incomplete course of vaccination. The patient inquired whether he should receive his 2nd dose now or if he should restart the vaccine Series, also inquired how long after his 2nd dose, he could receive the flu vaccine.  The reporter did not consent to follow-up.
patient received vaccination. patient appeared very nervous about the vaccine. Patient and her mother went to the front of the store to get something to drink at which time the patient fainted for a moment. The patient quickly came to, we assisted her for a few moments then she recovered and was able to walk out of the store. The patient's mother also stated that she had not eaten dinner yet that day. called to check on the patient later in the evening and her mother stated that she was doing well.
felt nauseous; face numb and tingling; face numb and tingling; This is a spontaneous report received from a contactable consumer (patient reported himself) via Medical Information Team. A 53-year-old male consumer received first dose of (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 21Apr2021 as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, "E-transmitting possible duplicate AE (this report may contain additional information not shared prior to transfer to the Medical Information. Caller stated he had already reported this to the previous agent). First dose of Pfizer on 21Apr2021, side effects started, 5 minutes after shot, felt nauseous. 10 minutes later, face numb and tingling and did not last long. He was no longer having side effects, they were all gone that day. He saw his PCP before the second dose and would talk to him". Caller asked whether the small side effects were from the first Pfizer vaccine, should he get the second. Response received included: As noted in the Fact Sheet for Recipients, should not get the Pfizer-BioNTech COVID-19 Vaccine if he had a severe allergic reaction after a previous dose of the vaccine or if he had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason could not be made by Pfizer. He was referred to speak to his healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. Healthcare provider would know his health situation and would have access to information that can better help inform this decision". No PQC present. Outcome of the events was recovered on 21Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient was to receive Shingrix vaccination. Vials pulled from box were for Menveo vaccination. Vials were not verified, only information on box. When document, error was noticed. Provider and patient were both notified. Patient is not having any adverse reactions.
Fatigue, body aches, headache, fever, chills, sweats, severe chest pain and chest tightness
Given the vaccine on day 31 days of expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given the vaccine on day 31 days of expiry) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given the vaccine on day 31 days of expiry). On 14-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Given the vaccine on day 31 days of expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was reported.    This case was linked to MOD-2021-353224, MOD-2021-353228, MOD-2021-353241, MOD-2021-353252, MOD-2021-353261, MOD-2021-353569, MOD-2021-353578, MOD-2021-353593, MOD-2021-353262 (Patient Link).
01/29/2021 Felt lightheaded immediately after vaccine, nauseous, lymph nodes in neck swelled, one under right arm was very big by bedtime. Fatigue. I had shortness of breath a few hours later. I have a difficult time catching my breaths sometimes too. Bad headache with sharp pain. Still experiencing these symptoms. Memory fog continues to this day. I have been accepted into the COVID clinic and will have my first visit on August 31st. Visited ER. I have also had debilitating widespread body cramps. 03/05/2021 Neck lymph nodes swelled, left and right. Headache was very pronounced but dull. All side effects from vaccine one persist into vaccine two. I continue to be extremely fatigued, I missed work the entire month of January. My neck is so stiff and this is a new side effect that just began with the second vaccine.
Severe body aches and fever for 24 hours. Tylenol used as needed.
Information has been received from a physician concerning a 64 year old male who on 02-NOV-2007 was vaccinated with a single dose of ZOSTAVAX (Oka/Merck) SQ (lot# 658398/1087U). On 15-JUL-2008 the patient experienced Shingles. The patient was treated with VALTREX. The patient sought unspecified medical attention. Additional information has been requested.
This patient received yellow fever vaccination subcutaneously to left posterior tricep area. The patient presents on 03/01 at 2:14 PM. The area was examined and he had a 2.0 x 2 1/2 cm raised indurated area.
Itching and redness starting 3 or 4 days after, worsening in day 8
Approximately 30 second after injection patient reported feeling nauseated and then passed out. Patient regained consciousness a minute later. Her vision and pulse rate was back to normal within 5 minutes. She was given juice and was able to walk to observation where she remained for at least 30 minutes.
Not feeling well; sinus or seasonal allergies; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), HYPERSENSITIVITY (sinus or seasonal allergies) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced HEADACHE (Headache). On 22-Mar-2021, the patient experienced MALAISE (Not feeling well) and HYPERSENSITIVITY (sinus or seasonal allergies). On 24-Feb-2021, HEADACHE (Headache) had resolved. At the time of the report, MALAISE (Not feeling well) and HYPERSENSITIVITY (sinus or seasonal allergies) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: other (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        The concomitant medications and treatment details were not provided. Treatment information was not provided
fever,  body aches, pain in arm where injected, swelling on arm where injected, headache, moderate fatigue, chills, 12- 14 hours
ABNORMAL LAB, BILIRUBIN  11.8,  DIAGNOSED WITH tOXIC HEPATITIS, ON POWERFUL STEROIDS, WITH LONG TERM AFFECT. 2 HOSPITAL STAYS, ER VISIT, MANY TEST DONE
a great deal of hair loss; COVID-19 (mRNA) vaccine interfere with the Endocrine System; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 66-year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 30Mar2021 (Lot number: ER8727) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose, Lot EN6205, Anatomical site: Right arm, Route of administration: Intramuscular), administration date: 09Mar2021, for COVID-19 Immunization. The following information was reported: ALOPECIA (non-serious) with onset 2021, outcome "unknown", described as "a great deal of hair loss"; ENDOCRINE DISORDER (non-serious) with onset 2021, outcome "unknown", described as "COVID-19 (mRNA) vaccine interfere with the Endocrine System". The event "a great deal of hair loss" was evaluated at the physician office visit. Therapeutic measures were taken as a result of alopecia.  Additional information: Patient had no other vaccines within 4 weeks prior to vaccination. Patient had PRP treatment for the hair loss .Patient had no relevant tests and patient had no concomitant therapy.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date, the patient was vaccinated with ZOSTAVAX, 1 DF for prophylaxis. Other suspect therapies included VARIVAX. Concomitant therapies included sterile diluent. On an unknown date, the patient experienced wrong drug administered and no adverse event. The outcome of wrong drug administered and no adverse event is unknown. The reporter considered wrong drug administered and no adverse event to be not related to ZOSTAVAX and VARIVAX.
One week after my second dose, I began developing random hives on different parts of my body that were and are extremely itchy. I also get red streaked areas that are itchy as well.
CONFUSION, SHORT TERM MEMORY LOSS, DIZZINESS, LONG TERM MEMORY LOSS
mom reports pt was sluggish & irritable 2 days p/vax, 19AUG96, 3 days p/vax, pt c/o h/a, & t104-had febrile sz while mom on phone w/MD;pt hosp & CT scan & blood test revealed nothing;no event  during hosp stay;pt fell from barn a/vax
10/11/15 - insomnia - 10/12/15 - pain at injection site, redness and swelling at site, fever (101.4 degrees at MD)) - went to MD - started AUGMENTIN - 10/13/15 - went to ER - cultures taken, DECADRON given, improving but not yet resolved.
stomach pain; hyperpigmentation in the injection site; pain over the core bone; arm sore; pain at the injection site; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), VACCINATION SITE DISCOLOURATION (hyperpigmentation in the injection site), BONE PAIN (pain over the core bone), PAIN IN EXTREMITY (arm sore) and VACCINATION SITE PAIN (pain at the injection site) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029LCA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), VACCINATION SITE DISCOLOURATION (hyperpigmentation in the injection site), BONE PAIN (pain over the core bone), PAIN IN EXTREMITY (arm sore), VACCINATION SITE PAIN (pain at the injection site), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), VACCINATION SITE DISCOLOURATION (hyperpigmentation in the injection site), BONE PAIN (pain over the core bone), PAIN IN EXTREMITY (arm sore), VACCINATION SITE PAIN (pain at the injection site), NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Left Arm hives, swelling, hot and very sore lasted 2/12/21-2/16/21.
pt's mom recv vax;pt devel chicken pox w/ T & approx 3 dozen lesions on face, stomach & back;lesions lasted approx 5 days;2 siblings devel chicken pox;mom felt that there was transmission of virus from her to children;
One day post vax, pt stopped walking completely. The pt would only crawl around and wanted to be carried. Pt was diagnosed with external femoral tension. In September, 1999, the pt recovered. Additionally, it was noted per the mother "child has not been the same since." The reporter could not elaborate on what the mother meant by this statement. No further information is available.
my heartbeat starting being faster; shortness of breath; I had fever the whole day; diarrhea; a silly cough; This is a spontaneous report from a contactable consumer (patient) reported for herself that a female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for covid-19 immunisation. Patient received the second dose of the Pfizer vaccine Monday. On Tuesday her heartbeat started being faster with shortness of breath. When she took a deep breath. She had to take a deep breath to get air into her lungs. She had fever the whole day. She didn't take any medications because she was told not to. She went to the doctor. They did an electrocardiogram and blood test but everything was fine. The doctor didn't see anything. She also have diarrhea and a silly cough. All the symptoms started after she got the vaccine. She is curious to know if these symptoms are associated with the vaccine. This generally never happens to Her. Outcome of the events was unknown.   No follow-up attempts are possible. Information about batch/lot number could not be obtained.
12 hours after vaccine, started getting tired, hot, arm pain. Worsened over night, with headache and extreme fatigue.
Pt recvd vax 30DEC91 in afternoon; had episode of unconsoloable crying x 3 hrs per mom also inc temp over 102 p/being given APAP drops; mom took pt to MD & was told by MD pt had rxn to Pertussis & to receive only DT in the future;
Two days after moderna covid vaccine I woke up with coarse throat, four days later a heavy tight chest and shortness of breath lasting another week and a half.
Immediately upon administration of the Varicella and PENTACEL (left thigh), there was swelling and redness at the injection sites and surrounding circumference. The same occurred on the right thigh with the administration of the MMR and PREVNAR.
Redness, swelling ANT  LT Thigh, delayed onset after immunizations 4/9 am, either soft tissue infection (cellulitis) vs delayed and severe local reaction (Photo attached color copy available)
8 hours after, fever, chills, body aches. 5 days later, severe headache that has lasted over a week (9 days)
UNCONSCIOUSNESS WITHIN MINUTES AND COULD NOT REGAIN SUSTAINED CONSCIOUSNESS; BODY IMMEDIATELY WENT INTO SHOCK; This spontaneous report received from social media from a parent via a company representative concerned a 19 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown) frequency one total, dose was not reported, administered on 10-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  The parent reported that the healthy patient after receiving vaccine on 10-MAY-2021, experienced unconsciousness within minutes and could not regain sustained consciousness. He was rushed to the emergency room via ambulance and ran some tests, found nothing of significance. His body immediately went into shock. The patient seemed stable now. He was admitted to the hospital on 10-MAY-2021 and the duration of hospitalization was not reported. Laboratory data included: Lab test (NR: not provided) Found nothing of significance. Discharge date of hospitalization was not specified. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from unconsciousness within minutes and could not regain sustained consciousness, and body immediately went into shock. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20210521196-JANSSEN COVID-19 VACCINE-unconscious within minutes and could not regain sustained consciousness, body immediately went into shock. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Information has been received from a registered nurse and a physician referring to a 12 months old patient of unknown gender. Concurrent conditions and medical history were not reported. On 06-FEB-2015, the patient was vaccinated with a dose of improperly stored (Oka/Mrerck) (lot # J005693, expire date 07-MAY-2015, dose, route, anatomical location were not reported). No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information is not expected since all the follow up has been done.
The first dose I had a sore arm, 2nd dose I couldn't move in the middle of the night. Kidney pain that lasted about a week. 3rd dose I was fine until I had shoulder pain, back pain, & lymph node enlargement in chest & arm pit as well as swelling. It would come up then come down.